nature
healthinsightjournal.com
Global Rank
#207,627
Country Rank
USA
#43,154
Industry Rank
Health/Health
#963

  • 2025-06-07 2025-06-11
    • nature
    Neuropathy is not from Low vitamin B. Meet the Real Enemy of Neuropathy (Stop Doing This)

    Health Insight Journal

  • 2025-05-30 2025-06-11
    • nature
    Neuropathy is not from Low vitamin B. Meet the Real Enemy of Neuropathy (Stop Doing This)

    Health Insight Journal

    Unlock
  • 2025-05-09 2025-05-09
    • nature
    Tüftler bricht Schweigen: Hausbesitzer sollten kein Solar kaufen, sondern...

    Anzeige - Solaranlagen Magazin

    • 0 0
    • Outbrain
    Unlock
  • 2025-05-09 2025-05-09
    • nature
    Tüftler bricht Schweigen: Hausbesitzer sollten kein Solar kaufen, sondern...

    Anzeige - Solaranlagen Magazin

    • 0 0
    • Outbrain
    nature
    nature
    Unlock
    nature
    Unlock
    nature
    The provided webpage discusses neuropathy, a condition characterized by nerve damage causing pain, tingling, and numbness, primarily in the feet. It critiques conventional treatments like Gabapentin and Lyrica, which suppress pain signals but fail to address the underlying cause while introducing side effects such as dizziness, fatigue, and organ-related complications. The content highlights Dr. Jeremy Campbell's perspective that neuropathy stems from oxygen-deprived nerve cells in the feet due to reduced blood flow, exacerbated by aging, diabetes, or decreased bodily fluids. This oxygen def...
    The provided webpage discusses neuropathy, a condition characterized by nerve damage causing pain, tingling, and numbness, primarily in the feet. It critiques conventional treatments like Gabapentin and Lyrica, which suppress pain signals but fail to address the underlying cause while introducing side effects such as dizziness, fatigue, and organ-related complications. The content highlights Dr. Jeremy Campbell's perspective that neuropathy stems from oxygen-deprived nerve cells in the feet due to reduced blood flow, exacerbated by aging, diabetes, or decreased bodily fluids. This oxygen deficiency leads to nerve deterioration and persistent symptoms. The article proposes an alternative: the Nooro Foot Massager 2.0, a device utilizing Neuromuscular Electrical Stimulation (NMES) to improve blood circulation and deliver oxygen to affected nerves. Developed in collaboration with Dr. Campbell, the device employs copper fiber fabric to enhance electrical conductivity, allowing deeper penetration of impulses to stimulate nerve recovery. Features include adjustable intensity/modes via remote control, ergonomic design, extended battery life, and durable construction. Unlike traditional massagers, its copper-infused material ensures impulses reach nerve tissues beneath the skin, promoting healing rather than temporary relief. The summary outlines the progression of neuropathy: persistent pain indicates living nerve cells capable of regeneration, as affirmed by the National Institute of Health, making early intervention critical. The Nooro Foot Massager 2.0 is presented as a non-pharmacological solution to reverse nerve damage by addressing circulatory insufficiency. Users are advised to apply 15-minute daily sessions for optimal results, complementing a proactive approach to nerve health. Dr. Campbell’s credentials—spanning over a decade in physical therapy, pain management, and medical innovation—are cited to establish authority. While the device is marketed as superior to generic foot massagers, the content focuses on its technical advancements, user testimonials, and alignment with physiological principles. The summary emphasizes the interplay between circulation, nerve vitality, and long-term symptom mitigation, advocating for solutions targeting the root cause over pain suppression.
    Country
    Traffic Share
    USA
    49.25%
    Colombia
    7.33%
    Dominican Republic
    6.27%
    Australia
    5.52%
    Finland
    4.35%
    Unlock
    Publisher
    Percent Traffic
    Date first seen
    Date last seen
    Duration (Days)
    wnd.com Revcontent NewsMax Mgid
    		11.79% 2023-11-03 2025-05-15 559
    thechive.com Revcontent NewsMax
    		11.66% 2023-11-03 2025-05-15 559
    test.com Test
    		14.28% 2025-01-21 2025-01-22 1
    test.com Test
    		14.28% 2025-01-21 2025-01-22 1
    healthinsightjournal.com
    #207,627
    topicsift.com
    #80,065
    temu.com
    #30